Showing results (731-740 of 2,754) with videos related to

Sort By:
Pageof 276
British Journal of Urology|March 1, 1994
Association between patient characteristics and treatment history, and toxicity associated with methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) for advanced urothelial cancerM Igawa, H Kadena, M Ueda, et al.
Journal of Bioscience and Bioengineering|October 20, 2005
Cloning, nucleotide sequence and expression of the beta-N-acetylglucosaminidase gene from Aeromonas sp. no. 10S-24M Ueda, Y Fujita, T Kawaguchi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Factors affecting the outcome of patients with advanced urothelial cancer following chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatinM Igawa, T Ohkuchi, M Ueda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 10, 2000
[Adult Wilms' tumor: a case report]K Abe, T Wada, M Ueda, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|October 16, 1999
Application of titanium-alloy endodontic implants in conjunction with periradicular surgeryY Sumi, Y Nakamura, K Mitsudoh, et al.
Applied Microbiology and Biotechnology|January 10, 2002
Cell surface-engineered yeast displaying a histidine oligopeptide (hexa-His) has enhanced adsorption of and tolerance to heavy metal ionsK Kuroda, S Shibasaki, M Ueda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 7, 2000
[Transitional cell carcinoma of urachus: a case report]K Abe, T Wada, M Ueda, et al.
Anesthesiology|October 19, 2001
Role of potassium channels in isoflurane- and sevoflurane-induced attenuation of hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungsR Liu, M Ueda, N Okazaki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimenM Igawa, H Kadena, M Ueda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 1, 1994
M-VEC (methotrexate, vinblastine, 4'-epirubicin and cisplatin) combined with glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the treatment of transitional cell carcinoma of urothelium: reduction in toxicity produced by rhG-CSFM Ueda, M Igawa, H Kadena, et al.
Pageof 276